Cargando…

Targeting microglial NLRP3 in the SNc region as a promising disease‐modifying therapy for Parkinson's disease

INTRODUCTION: Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive loss of dopaminergic (DA) neurons. Accumulating evidence has shown that activation of the NLR family pyrin domain‐containing 3 (NLRP3) inflammasome is an early and cardinal feature in PD progress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Chen, Dang, Tao, Zhou, Yan, Zhou, Yuan‐Zhang, Zhao, Rong, Wang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660492/ https://www.ncbi.nlm.nih.gov/pubmed/36199191 http://dx.doi.org/10.1002/brb3.2784

Ejemplares similares

Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease
por: Yan, Yi‐Qun, et al.
Publicado: (2023)

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
por: Li, Yunna, et al.
Publicado: (2021)

Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s disease
por: Zhou, Xiao-Gang, et al.
Publicado: (2022)

Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

sncRNA changes induced by tension in hypertrophic scar: sncRNAs in hypertrophic scar
por: Yin, Chuang, et al.
Publicado: (2022)

The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
por: Kou, Liang, et al.
Publicado: (2022)

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
por: Richardson, Jason R., et al.
Publicado: (2013)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction
por: Xu, Long, et al.
Publicado: (2023)

Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
por: Janda, Elzbieta, et al.
Publicado: (2018)

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
por: Subramaniam, Sudhakar R., et al.
Publicado: (2017)

Oxidative Stress and Microglial Cells in Parkinson's Disease
por: Peterson, Lynda J., et al.
Publicado: (2012)

The disease resistance protein SNC1 represses the biogenesis of microRNAs and phased siRNAs
por: Cai, Qiang, et al.
Publicado: (2018)

sncRNAs in Epididymosomes: The Contribution to Embryonic Development and Offspring Health
por: Luo, Jingwen, et al.
Publicado: (2022)

Malformaciones congénitas del S.N.C. : defectos del cierre del tubo neural
por: Aguilar Nungaray, Sonia Patricia
Publicado: (1998)

Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease
por: Koshimori, Yuko, et al.
Publicado: (2015)

Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson’s Disease Models
por: Tada, Satoshi, et al.
Publicado: (2022)

Plasma-Derived Exosomal SncRNA as a Promising Diagnostic Biomarker for Early Detection of HBV-Related Acute-on-Chronic Liver Failure
por: Xu, Wenli, et al.
Publicado: (2022)

Aging Induces Profound Changes in sncRNA in Rat Sperm and These Changes Are Modified by Perinatal Exposure to Environmental Flame Retardant
por: Suvorov, Alexander, et al.
Publicado: (2020)

Promising drug targets and associated therapeutic interventions in Parkinson’s disease
por: Rai, Sachchida Nand, et al.
Publicado: (2021)

Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
por: Das, Biswadeep, et al.
Publicado: (2021)

ZIKV – CDB: A Collaborative Database to Guide Research Linking SncRNAs and ZIKA Virus Disease Symptoms
por: Pylro, Victor Satler, et al.
Publicado: (2016)

Author Correction: The disease resistance protein SNC1 represses the biogenesis of microRNAs and phased siRNAs
por: Cai, Qiang, et al.
Publicado: (2019)

Microglial activation in Parkinson’s disease using [(18)F]-FEPPA
por: Ghadery, Christine, et al.
Publicado: (2017)

The microglial immunoreceptor tyrosine‐based motif‐Syk signaling pathway is a promising target of immunotherapy for Alzheimer's disease
por: Wang, Shoutang, et al.
Publicado: (2023)

Interaction between HIV and its host: role for viral and cellular sncRNA
por: Benkirane, Monsef
Publicado: (2011)

SncRNA715 Inhibits Schwann Cell Myelin Basic Protein Synthesis
por: Müller, Christina, et al.
Publicado: (2015)

Mest/Peg1 Is Essential for the Development and Maintenance of a SNc Neuronal Subset
por: Mesman, Simone, et al.
Publicado: (2017)

The sncRNA Zoo: a repository for circulating small noncoding RNAs in animals
por: Fehlmann, Tobias, et al.
Publicado: (2019)

Arousal State-Dependent Alterations in Neural Activity in the Zebra Finch VTA/SNc
por: Yanagihara, Shin, et al.
Publicado: (2020)

The proteasome regulator PTRE1 contributes to the turnover of SNC1 immune receptor
por: Thulasi Devendrakumar, Karen, et al.
Publicado: (2019)

Neural correlates of vocal initiation in the VTA/SNc of juvenile male zebra finches
por: Yanagihara, Shin, et al.
Publicado: (2021)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

The role of NLRP3 inflammasome for microglial response to peripheral inflammation
por: Garaschuk, Olga
Publicado: (2020)

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
por: Kelly, Rachel, et al.
Publicado: (2020)

Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease
por: Liu, Yang, et al.
Publicado: (2023)

Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease
por: Panicker, Nikhil, et al.
Publicado: (2019)

Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
por: Nguyen, Linh Thi Nhat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nv66rgntokfn57jb6g3ve9g58i